Blog

Let’s board the Train to ESMO to Barcelona – ESMO4Climate

Photo from ESMO/LinkedIn

Jul 11, 2024, 14:45

Let’s board the Train to ESMO to Barcelona – ESMO4Climate

ESMO (European Society for Medical Oncology) shared a post on LinkedIn:

”ESMO4Climate: ESMO encourages delegates to travel to ESMO24 in the most climate-friendly way possible, opting to take the train to Barcelona, where feasible.

Learn more about the Train To ESMO initiative and the discounts available.”

Source: ESMO/LinkedIn

cancer ESMO ESMO24 European Society for Medical Oncology OncoDaily Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Insight

Jan 20, 2025, 12:28

Myeloma Paper of the Day, January 20th, suggested by Robert Orlowski

Blog

Jan 20, 2025, 12:26

The first seminar of 2025 NCI Rising Scholars: Cancer Research Seminar Series

Blog

Jan 20, 2025, 12:16

Rita A. Sakr: Honored to present dear breast cancer survivors at SABCS24

Blog

Jan 20, 2025, 12:11

Catharine Young: Real progress doesn’t happen in isolation

Blog

Jan 20, 2025, 11:28

Fernanda Rivera's Journey as the first Mexican RadOnc Resident to receive the ASCO IDEA Award

Blog

Jan 20, 2025, 04:32

Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma

Blog

Jan 20, 2025, 04:29

Katsuaki Maehara: Lung EGFR mutations catalog

Opinion

Jan 20, 2025, 04:25

Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities

Blog

Jan 20, 2025, 04:21

Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family

Insight

Jan 20, 2025, 04:14

Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra

Insight

Jan 20, 2025, 04:00

FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

Career

Jan 20, 2025, 03:10

Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research